Responsibility is one incentive when retail investors seek investments. Pharmaceuticals and healthcare is one of the most interesting sectors.
Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.
Orion published Financial Statement Release for 2019 on Wednesday, 5 February 2020. The release, presentation material and link to live webcast recording are available here.
Orion Investor Relations have received several questions related to the coronavirus (COVID-19) pandemia and its impacts on Orion. We have listed here answers to some frequently asked questions.
Orion Group's Financial Statement documents for 2019 are available here.
Information and instructions for shareholders who have shares on joint account.
Orion's Capital Markets Day was held on Wednesday 22 May 2019.
Impact of Darolutamide on Pain and Quality of Life in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer (nmCRPC) at ASCO taking place in Chicago.
The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.
Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.
Monthly updated list of Orion's major shareholders by votes.
Orion Corporation has been included in the globally recognised FTSE4Good Index.
